DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Personalized Decision Support for Older Patients With Diabetes

Not Applicable

Completed

Conditions: Diabetes

Interventions: Other: Personalized Diabetes Care Website

First Posted Date: 2014-06-23

Last Posted Date: 2016-02-19

Lead Sponsor: University of Chicago

Target Recruit Count: 100

Registration Number: NCT02169999

Locations: 🇺🇸
University of Chicago Hospitals, Chicago, Illinois, United States

The Effect of NSAIDs After a Rotator Cuff Repair Surgery.

Phase 4

Withdrawn

Conditions: Rotator Cuff Tear

Interventions: Procedure: Rotator cuff repair
Drug: Ibuprofen, Hydrocodone/Acetaminophen, Omeprazole
Drug: Hydrocodone/Acetaminophen

First Posted Date: 2014-06-02

Last Posted Date: 2023-02-23

Lead Sponsor: University of Chicago

Registration Number: NCT02153177

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors

Phase 1

Completed

Conditions: Breast Neoplasms
Lung Neoplasms
Cancer of Liver
Lymphoma
Cancer of Kidney

Interventions: Drug: Metformin XR
Drug: Delayed Metformin
Drug: Sirolimus

First Posted Date: 2014-05-23

Last Posted Date: 2019-04-22

Lead Sponsor: University of Chicago

Target Recruit Count: 24

Registration Number: NCT02145559

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2

Active, not recruiting

Conditions: Brenner Tumor
Malignant Pleural Effusion
Ovarian Endometrioid Adenocarcinoma
Recurrent Fallopian Tube Cancer
Recurrent Primary Peritoneal Cavity Cancer
Ovarian Clear Cell Cystadenocarcinoma
Stage IIIC Fallopian Tube Cancer
Malignant Ascites
Ovarian Mixed Epithelial Carcinoma
Recurrent Ovarian Epithelial Cancer

Interventions: Drug: metformin hydrochloride
Drug: placebo
Drug: Chemotherapy

First Posted Date: 2014-04-24

Last Posted Date: 2024-07-31

Lead Sponsor: University of Chicago

Target Recruit Count: 110

Registration Number: NCT02122185

Locations: 🇺🇸
Mitchell Cancer Institute - University of South Alabama, Mobile, Alabama, United States
🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸
City of Hope, Duarte, California, United States

and more 7 locations

Afatinib in Advanced Refractory Urothelial Cancer

Phase 2

Terminated

Conditions: Distal Urethral Cancer
Recurrent Bladder Cancer
Proximal Urethral Cancer
Recurrent Urethral Cancer
Stage III Bladder Cancer
Stage III Urethral Cancer
Stage IV Bladder Cancer
Stage IV Urethral Cancer
Ureter Cancer

Interventions: Drug: afatinib dimaleate
Other: laboratory biomarker analysis

First Posted Date: 2014-04-24

Last Posted Date: 2025-04-25

Lead Sponsor: University of Chicago

Target Recruit Count: 32

Registration Number: NCT02122172

Locations: 🇺🇸
NorthShore University Health System, Evanston, Illinois, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States

and more 3 locations

Epidural Catheter With or Without Adductor Canal Nerve Block for Postoperative Analgesia Following Total Knee Arthroplasty

Not Applicable

Completed

Conditions: Arthroplasty, Replacement, Knee
Nerve Block

Interventions: Device: Adductor Canal Nerve Block Sham Catheter
Device: Adductor Canal Nerve Block Catheter
Drug: Bupivacaine

First Posted Date: 2014-04-23

Last Posted Date: 2020-10-20

Lead Sponsor: University of Chicago

Target Recruit Count: 165

Registration Number: NCT02121392

Locations: 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States

Vasoactive Drugs in Intensive Care Unit

Phase 4

Recruiting

Conditions: Shock

Interventions: Drug: Norepinephrine
Drug: Phenylephrine
Drug: Epinephrine
Drug: Vasopressin

First Posted Date: 2014-04-21

Last Posted Date: 2024-12-09

Lead Sponsor: University of Chicago

Target Recruit Count: 836

Registration Number: NCT02118467

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Outcomes of Biceps Tenodesis or Labral Repair for Treatment of Type 2 Superior Labrum Anterior and Posterior Lesions

Not Applicable

Completed

Conditions: Type 2 SLAP Lesions

Interventions: Procedure: Biceps tenodesis
Procedure: Labral repair

First Posted Date: 2014-04-08

Last Posted Date: 2023-04-26

Lead Sponsor: University of Chicago

Target Recruit Count: 20

Registration Number: NCT02107547

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States

Comparison of Outcomes Between Biceps Tenotomy and Tenodesis in the Treatment of the Long Head of the Biceps Pathology

Not Applicable

Completed

Conditions: Chronic Refractive Bicipital Pain

Interventions: Procedure: Biceps tenotomy
Procedure: Biceps tenodesis

First Posted Date: 2014-04-08

Last Posted Date: 2023-04-26

Lead Sponsor: University of Chicago

Target Recruit Count: 6

Registration Number: NCT02107586

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Comparing the Outcomes Between Rotator Cuff Repair With and Without Suprascapular Nerve Decompression

Not Applicable

Completed

Conditions: Rotator Cuff Tear

Interventions: Procedure: Rotator Cuff Repair without Suprascapular Nerve decompression
Procedure: Rotator Cuff Repair with Suprascapular Nerve decompression

First Posted Date: 2014-04-08

Last Posted Date: 2025-05-11

Lead Sponsor: University of Chicago

Target Recruit Count: 36

Registration Number: NCT02107573

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States
🇺🇸
Northshore University, Evanston, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy